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Abstract
The negative initial endoscopy investigations (gastroscopy and colonoscopy) are the basic conditions for the obscure
gastrointestinal (GI) bleeding diagnosis. The bleeding source is mostly localized in the small bowel; in spite of this, there is
still a large group of patients with upper GI lesions missed during initial gastroscopy. Therefore, the capsule endoscopy
indicated as the ﬁrst-line method can be valuable for the gastric and duodenal investigation, too. Some cases of missed
upper GI lesions diagnosed by means of capsule endoscopy indicated for obscure GI bleeding are demonstrated. This article
is part of an expert video encyclopedia.
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Video Related to this Article
Materials
• Wireless capsule endoscopy: Given Imaging – Pillcam,
Israel; Olympus – EndoCapsule, Tokyo, Japan.
• Double-balloon enteroscopy: Fujinon EN-450T5; Tokyo,
Japan.
• Gastroscopy: Olympus GIF Q 180; Tokyo, Japan.
Background and Endoscopic Procedures
Obscure gastrointestinal (GI) bleeding is deﬁned as bleeding
into the GI tract that persists or recurs without any evident
source identiﬁed after initial endoscopy (gastroscopy and
colonoscopy). Clinical presentation can be overt (melena and/
or hematochesia) or occult bleeding (iron-deﬁciency anemia
and/or positive fecal occult blood test). Obscure GI bleeding
may occur anywhere throughout the GI tract; the bleeding
source is mostly localized in the small bowel.1,2 Many studies
comparing wireless capsule endoscopy (WCE) to other im-
aging methods (endoscopic or radiologic) conﬁrmed the
highest diagnostic accuracy of WCE in patients with obscure
GI bleeding.3–5 WCE is the ﬁrst-line method in the standard
algorithms followed by therapeutic enteroscopy, drug treat-
ment, or surgery. In spite of this fact, substantial endoscopic
miss rates have also been reported during initial standard
gastroscopies.6–8
There are two important questions in patients with obscure
GI bleeding in this context. The ﬁrst one is: When should we
repeat gastroscopy before WCE? Risk factors associated with
higher number of missed upper GI lesions are large hiatal
hernias, hematemesis, and treatment by nonsteroidal anti-
inﬂammatory drugs (NSAIDs).9 In cases of obscure GI
bleeding with negative initial gastroscopy, repeated standard
endoscopy should be done in any doubt about the quality of
ﬁrst gastroscopy too (absence of video recording, retroversion
or deep duodenal intubation, and large amount of gastric
content with remnants of food or blood limiting investi-
gation). The second question: Is there clinical ability of WCE
in identifying the missed upper GI lesions? Although WCE is
dedicated to explore the small bowel, it also provides quality
images of the esophagus and stomach recorded before the
passage through the pylorus. In retrospective analysis (pub-
lished in cooperation with Belgian colleagues), 10 gastric le-
sions were observed in 37% (44/118) of patients undergoing
WCE for obscure GI bleeding, and the lesions were considered
as signiﬁcant (potentially hemorrhagic) in 21% (25/118) of
them. The identiﬁed pathology was subsequently considered
as the only source of bleeding in 10% (12/118) of patients.
Missed lesions in the upper GI tract included hemorrhagic
erosions, portal gastropathy with blood, ulcers, angiectasias,
Dieulafoy’s lesions, Cameron ulcer, and gastric antral vascular
ectasias. Most of these lesions were described in the gastric
body or in the antrum, conﬁrming existing limits of WCE for
evaluation of the fundus and cardia. On the contrary, the
pylorus and prepyloric area were regularly observed in most
cases.10 There were no statistically signiﬁcant differences be-
tween the number of potentially hemorrhagic gastric lesions
detected by means of WCE in patients with obscure overt
(15/25) or occult (10/25) GI bleeding. There are some pos-
sible limits of WCE in these cases. The quick passage of
the capsule through the esophagus limits the quality of visu-
alization; usually only a few pictures from the distal part
This article is part of an expert video encyclopedia. Click here for the full
Table of Contents.
Video Journal and Encyclopedia of GI Endoscopy http://dx.doi.org/10.1016/S2212-0971(13)70075-X
Video available to view or download at doi:10.1016/S2212- 
0971(13)70075-X
180
Open access under CC BY-NC-ND license.
could be evaluated. Important factors limiting the visibility
of the stomach are inability of insufﬂation and presence of
gastric content despite adequate fasting. Another speciﬁc
problem of WCE is poor visibility of periampular region with
the risk of missing the lesions (important particularly in pa-
tients with inadequate duodenal intubation during initial
gastroscopy).
A video case of missed upper GI lesion during gastroscopy
and identiﬁed by subsequent enteroscopy has been presented. A
73-year-old man with dual antiaggregation therapy was in-
vestigated because of recurrent GI bleeding requiring repeated
blood transfusions (8 units during 3 months). Initial gastro-
scopy and colonoscopy were accomplished elsewhere with
normal ﬁndings. Capsule endoscopy performed in the authors’
department identiﬁed a pedunculated tumor in the proximal
small bowel. Double-balloon enteroscopy conﬁrmed a ﬁnger-
like giant polyp growing from the distal duodenum and
reaching the proximal jejunum. The length of the polyp was 12
and its diameter 2 cm. Because of the patient’s serious comor-
bidity, it was decided to remove the polyp endoscopically. The
polyp was extracted for histology and the ﬁnal diagnosis was
vascular lipoﬁbroma (angiolipoﬁbroma).
Gastroscopy and colonoscopy are the initial basic investi-
gations in patients with GI bleeding from unknown origin. In
the case of negative results, the source of bleeding in the small
intestine is supposed. Capsule enteroscopy is the ﬁrst-line
method for detection of small intestinal pathology, although
some missed lesions within reach of either gastroscopy or
colonoscopy could be found as well.
Key Learning Points/Tips and Tricks
• The prevalence of upper GI lesions in patients with obscure
GI bleeding is relatively high (especially in patients with
axial hiatal hernia, hematemesis, and NSAID therapy).
• Reevaluate the quality of the initial gastroscopy and read
the ‘upper’ part of the WCE.
Scripted Voiceover
Time (min:sec) Voiceover text
00:00–00:30 The topic of our video presentation are upper
gastrointestinal lesions detected by capsule
endoscopy in patients with obscure
gastrointestinal bleeding. We present some
examples of missed lesions in the upper
gastrointestinal tract identiﬁed by means of
wireless capsule endoscopy. This is a typical
picture of portal hypertensive gastropathy in the
gastric body with characteristic mosaic-like
pattern and red spots.
00:30–00:40 In another patient, the source of bleeding was
identiﬁed as several hemorrhagic erosions
localized in the gastric antrum.
00:40–00:52 The small linear antral ulcer was found by capsule
endoscopy in a patient treated with nonsteroidal
anti-inﬂammatory drugs.
00:52–01:10 The presence of digested blood, or clots in the
stomach at capsule endoscopy, conﬁrms the
suspicion of an overlooked gastric lesion. In this
patient, the gastric angiectasia was the source of
obscure bleeding.
01:10–01:24 An example of intermittent bleeding pathology
localized in the duodenum is this Dieulafoy’s
lesion, treated by means of bipolar
electrocoagulation during the second
gastroscopy.
01:24–01:36 Small lesions, like this ulcerated gastrointestinal
stromal tumor, can be missed due to intestinal
content (e.g., bile or bubbles) in the duodenal
area.
01:40–02:15 We present a video case of upper gastrointestinal
lesion missed at initial gastroscopy, identiﬁed by
subsequent enteroscopy methods. A 73-year-old
man with dual antiaggregation therapy was
investigated due to recurrent gastrointestinal
bleeding and repeated blood transfusions. The
initial gastroscopy and colonoscopy were
accomplished elsewhere with normal ﬁndings.
Wireless capsule endoscopy identiﬁed an
abnormal fold in the duodenum (on 6 and 4 h)
and a suspected polyp, with abnormal mucosa,
on the frozen picture here on 11 h.
02:17–02:37 The double-balloon enteroscopy conﬁrmed a
ﬁnger-like giant polyp growing from the
duodenum. The length of the polyp was
12 cm and its diameter 2 cm, the tip, with
oedematous mucosa, was localized in the
proximal jejunum.
03:06–03:36 Because of the patient’s comorbidity, we decided
to remove the polyp endoscopically. Risk of
serious bleeding was expected, so we set an
endoloop and hemoclips on the polyp base. The
snare polypectomy time was unusually long and
we observed intensive bleeding from the polyp
stump.
03:41–04:07 The bleeding was controlled by means of argon
plasmacoagulation of the whole area.
04:08–04:17 The polyp was extracted for histology, and the
ﬁnal diagnosis was angiolipoﬁbroma.
04:19–04:29 Control endoscopies 24 h and 9 day after
polypectomy conﬁrmed uncomplicated healing
of the polyp stump.
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